OssDsign reports exceptional data from the clinical study TO

OssDsign reports exceptional data from the clinical study TOP FUSION

Uppsala, January 9, 2024. OssDsign AB today announces that positive data from the clinical study TOP FUSION has been submitted to a peer-reviewed scientific journal. Top-line results show a 93 %...

Related Keywords

Hungary , Budapest , Morten Henneveld , National Center , Metrics Inc , Buda Health Clinic , Ossdsign Catalyst , Spinal Disorders , Health Clinic , Dsign Catalyst , Abuse Regulation ,

© 2025 Vimarsana